• 3483 Citations
  • 23 h-Index
1988 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Alessandro Corso is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles
Multiple Myeloma Medicine & Life Sciences
Dexamethasone Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Thalidomide Medicine & Life Sciences
zoledronic acid Medicine & Life Sciences
Etoposide Medicine & Life Sciences
Cyclophosphamide Medicine & Life Sciences
Monoclonal Gammopathy of Undetermined Significance Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1988 2019

  • 3483 Citations
  • 23 h-Index
  • 110 Article
  • 1 Letter

Management of infectious complications in multiple myeloma patients: Expert panel consensus-based recommendations

Girmenia, C., Cavo, M., Offidani, M., Scaglione, F., Corso, A., Di Raimondo, F., Musto, P., Petrucci, M. T. & Barosi, G., Jan 1 2019, (Accepted/In press) In : Blood Reviews.

Research output: Contribution to journalArticle

Multiple Myeloma
Literature
Proteasome Inhibitors
Passive Immunization
Intravenous Immunoglobulins

Smoldering multiple myeloma: the role of different scoring systems in identifying high-risk patients in real-life practice

Cocito, F., Mangiacavalli, S., Valeria Ferretti, V., Cartia, C. S., Ganzetti, M., Benveuti, P., Pompa, A., Catalano, M., Fugazza, E., Landini, B., Arcaini, L. & Corso, A., Jan 1 2019, In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

Multiple Myeloma
Bone Marrow
Light
Plasma Cells
Serum

Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study)

Musto, P., Simeon, V., Cascavilla, N., Falcone, A., Petrucci, M. T., Cesini, L., Di Raimondo, F., Conticello, C., Ria, R., Catalano, L., Salvatore, D., Mastrullo, L., Gagliardi, A., Villani, O., Pietrantuono, G., D'Arena, G., Mansueto, G., Bringhen, S., Genuardi, M., Di Renzo, N. & 8 others, Reddiconto, G., Fragasso, A., Caravita, T., Scapicchio, D., Marziano, G., Boccadoro, M., Mangiacavalli, S. & Corso, A., Oct 23 2018, In : Annals of Hematology.

Research output: Contribution to journalArticle

Salvage Therapy
Multiple Myeloma
Therapeutics
Recurrence
Drug Combinations

Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study)

Musto, P., Simeon, V., Cascavilla, N., Falcone, A., Petrucci, M. T., Cesini, L., Di Raimondo, F., Conticello, C., Ria, R., Catalano, L., Salvatore, D., Mastrullo, L., Gagliardi, A., Villani, O., Pietrantuono, G., D’Arena, G., Mansueto, G., Bringhen, S., Genuardi, M., Di Renzo, N. & 8 others, Reddiconto, G., Fragasso, A., Caravita, T., Scapicchio, D., Marziano, G., Boccadoro, M., Mangiacavalli, S. & Corso, A., Jan 1 2018, (Accepted/In press) In : Annals of Hematology.

Research output: Contribution to journalArticle

Salvage Therapy
Multiple Myeloma
Therapeutics
Recurrence
Drug Combinations
4 Citations (Scopus)

Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study

EMMOS Investigators, Jan 1 2018, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

Multiple Myeloma
Stem Cell Transplantation
Thalidomide
Cell Transplantation
Therapeutics